NVST - Envista Holdings Corp
NEXT EARNINGS:
May 7, 2026
EPS Est: $0.31
|
Rev Est: $679.6M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$27.22
DETAILS
HIGH:
$35.00
LOW:
$19.00
MEDIAN:
$25.00
CONSENSUS:
$27.22
DOWNSIDE:
7.51%
Market Cap:
4.84B
Volume:
2,041,971
Avg Volume:
2,794,903
52 Week Range:
14.22-30.42
Sector:
Healthcare
Industry:
Medical - Equipment & Services
Beta:
1.00
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
12,300
IPO Date:
2019-09-18
EPS (TTM):
0.28
P/E Ratio:
77.60
Revenue (TTM):
2.72B
Total Assets:
5.68B
Total Debt:
1.71B
Cash & Equiv:
1.21B
Rev Growth (5Y):
7.1%
EPS Growth (5Y):
0.7%
FCF Growth (5Y):
-0.5%
ROCE:
4.7%
Debt/Equity:
0.55
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-05 | $0.38 | $0.32 | +18.8% | $750.6M | $658.4M | +14.0% |
| 2025-10-29 | $0.32 | $0.27 | +18.5% | $669.9M | $680.3M | -1.5% |
| 2025-07-31 | $0.26 | $0.24 | +8.3% | $682.1M | $642.5M | +6.2% |
| 2025-05-01 | $0.24 | $0.20 | +20.0% | $616.9M | $635.7M | -3.0% |
| 2025-02-05 | $0.24 | $0.23 | +4.3% | $652.9M | $645.9M | +1.1% |
| 2024-10-30 | $0.12 | $0.09 | +33.3% | $601.0M | $647.7M | -7.2% |
| 2024-08-07 | $0.11 | $0.27 | -59.3% | $633.1M | $646.9M | -2.1% |
| 2024-05-01 | $0.26 | $0.31 | -16.1% | $623.6M | $634.1M | -1.7% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.72B | 2.51B | 2.57B | 2.57B | 2.51B | 1.93B | 2.28B | 2.84B | 2.81B | 2.79B |
| Net Income | 47.00M | (1.12B) | (100.20M) | 243.10M | 340.50M | 33.30M | 217.60M | 230.70M | 301.10M | 272.00M |
| EPS | 0.28 | -6.50 | -0.60 | 1.46 | 1.63 | 0.27 | 1.35 | 1.80 | 2.35 | 0.00 |
| Total Assets | 5.68B | 5.35B | 6.61B | 6.59B | 6.57B | 6.88B | 6.16B | 5.84B | 5.99B | N/A |
| Total Debt | 1.71B | 1.55B | 1.65B | 1.53B | 1.48B | 1.98B | 1.54B | 0 | 0 | N/A |
| Cash & Equivalents | 1.21B | 1.07B | 940.00M | 606.90M | 1.07B | 888.90M | 211.20M | 0 | 0 | N/A |
| Operating Cash Flow | 275.70M | 336.50M | 275.70M | 182.70M | 361.60M | 283.90M | 397.50M | 400.10M | 359.10M | 417.00M |
| Free Cash Flow | 230.40M | 302.70M | 217.50M | 107.00M | 306.90M | 236.20M | 319.70M | 327.90M | 310.20M | 367.90M |
| FCF per Share | 1.37 | 1.76 | 1.30 | 0.66 | 1.90 | 1.48 | 2.35 | 2.12 | 2.01 | 2.38 |
| Book Value | 3.11B | 2.93B | 4.17B | 4.21B | 4.06B | 3.72B | 3.54B | 4.82B | 4.99B | N/A |
| Cash & ST Investments | 1.21B | 1.07B | 940.00M | 606.90M | 1.07B | 888.90M | 211.20M | 0 | 0 | N/A |
| ROC Equity | 0.02 | -0.38 | -0.02 | 0.06 | 0.08 | 0.01 | 0.06 | 0.05 | 0.06 | N/A |